- Home
- A-Z Publications
- Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
- Fast Track Listing
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) - Online First
Description text for Online First listing goes here...
36
results
36 results
-
-
Bacteriocins from Lactic Acid Bacteria Could Modulate the Wnt Pathway: A Possible Therapeutic Candidate for the Management of Colorectal Cancer- An In silico Study
Available online: 12 March 2025More LessIntroduction Colorectal cancer (CRC) is a type of cancer that develops due to abnormal cell growth in the colon and rectum. Existing conventional CRC treatment strategies have side effects. Hence, exploring new and advanced techniques for bacterial CRC therapy is crucial. Bacteriocins are peptides produced by bacteria, including lactic acid bacteria (LAB), that have bactericidal effects. In the present study, we have focused Read More
-
-
-
Quercetin’s Potential Therapeutic Role in Human Colorectal Cancer: An Effective Strategy for Prevention and Treatment
Available online: 06 March 2025More LessBackground Colorectal cancer (CRC) is a significant global health burden, ranking third in incidence and second in mortality worldwide. The incidence of CRC continues to rise, and drug resistance to conventional therapies such as 5-fluorouracil (5-FU) poses a challenge in treatment. Quercetin, a naturally occurring flavonol, has shown anti-carcinogenic properties and potential in sensitizing cancer cells to chemothera Read More
-
-
-
Redefining Anthraquinone-based Anticancer Drug Design through Subtle Chemical Modifications
Authors: Bijayashree Mishra, Pratap Chandra Acharya and Utpal Chandra DeAvailable online: 03 March 2025More LessAnthraquinones are well known for their wide spectrum of pharmacological properties. Anthraquinone antibiotics, such as doxorubicin, daunorubicin, epirubicin, and mitoxantrone, have long been used in the clinical management of various tumors. However, their use is limited due to their toxicity effects, especially cardiomyopathy, despite their pronounced therapeutic effects. In recent years, medicinal chemists have Read More
-
-
-
A Path to the Formation Mechanism of Propolis Nanoparticles, their Cytotoxicity on 3T3 Fibroblasts, Metastatic Murine B16F10 Cells, and their In vivo Irritability in Animals
Available online: 26 February 2025More LessBackground Natural products such as propolis are an important source of biologically active compounds with the potential to treat health disorders. Propolis is a well-known waxy resin recognized for its antimicrobial immunomodulatory and cytotoxic effects Objective In this study we aimed to clarify the formation mechanism of propolis nanoparticles from the perspective of their stability and chemical composition. By evaluatin Read More
-
-
-
CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness
Authors: Wei Li, Jian Chen, Jinbao Yang, Bo Zhang, Dihao Wen and Zhibin JiangAvailable online: 12 February 2025More LessBackground This study explored whether the cell cycle regulator cadherin 1 (CDH1) impacts colorectal cancer cell cycle and stemness via mediating ubiquitination of sirtuin 5 (SIRT5). Methods We first constructed CDH1 overexpression plasmid and small interfering RNA against SIRT5 (siSIRT5) and transfected them into HCT116/HT29 cells, followed by transfection efficiency verification. The effect of CDH1 on Cyclin F/SI Read More
-
-
-
Recurrent Missense Driver STAT5B N642H Mutation in Children Transiting into Adolescence, with Acute Lymphoid Leukemia and its In silico Inhibition
Authors: Rehana Yasmin, Rashda Abbasi, Tajdar Jahangir Gohar, Hina, Nafees Ahmad and Sajid MalikAvailable online: 10 February 2025More LessBackground The occurrence of gain of function mutations in STAT5B has been associated to survival, and drug resistance in Leukemia. In silico screening of compounds having inhibitory potential towards mutated proteins, can be helpful in the development of specific inhibitors. Objective This study was designed to screen selected JAK-STAT mutations in leukemia patients and virtual exploration of molecular interaction of p Read More
-
-
-
A Systematic Quantitative Approach to Rational Drug Design and the Discovery of Novel Human Antigen R (HuR) Inhibitors
Authors: Juhi Dey, Kumari Kaushiki, KM Abha Mishra, Paga Sudheer and Kalyan Kumar SethiAvailable online: 04 February 2025More LessBackground 1,4-Naphthoquinone and its derivatives are recognized for their potent anticancer effects, establishing this pharmacophore as a key focus in cancer research. Their potential to modulate cellular pathways suggests they could be effective in developing new HuR inhibitors, targeting a protein crucial for regulating cancer-related gene expression. Compounds C1-C20 were designed by using Discovery Studio (DS) softw Read More
-
-
-
Design, Synthesis, and Molecular Docking Studies of Indolo[3,2-c]Quinolines as Topoisomerase Inhibitors
Available online: 03 February 2025More LessBackground The tetracyclic indoloquinoline ring system has attracted considerable interest in the recent past due to its broad spectrum of biological activities and its binding to various types of nucleic acids. Objective This study aims to elucidate their interactions with DNA and their effects on topoisomerases (TOPO) I and II. Methods Several compounds derived from 6-amino-11H-indolo[3,2-c]quinoline with diverse g Read More
-
-
-
In vitro and In vivo Growth Inhibition and Apoptosis of Cancer Cells by Ethyl 4-[(4-methylbenzyl)oxy] Benzoate Complex
Available online: 31 January 2025More LessBackground Cancer chemotherapy is one of the best ways to treat the patients with cancer as they can remove cancer cells, which can’t be remove by radiation or surgery. Aims Our study is focused on identifying potent chemotherapeutic drugs with minor or no adverse side effects. Therefore, in this study, we aimed to synthesize ethyl 4-[(4-methylbenzyl)oxy] benzoate complex, a macrocyclic aromatic compound foll Read More
-
-
-
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems
Authors: Lalit Kumar, Ritesh Rana, Nusrat K. Shaikh, Sumit Kumar, Vikas Aggarwal, Komal Komal, and and Vuluchala JyothiradityaAvailable online: 30 January 2025More LessIntroduction Prostate cancer is a major worldwide health concern, and existing treatments often face challenges such as drug resistance, systemic toxicity, and insufficient targeting. Polymeric nanocarriers are currently employed as sophisticated tools in the field of oncology, offering the possibility to augment the administration and efficacy of anticancer therapies. In order to effectively eradicate prostate cancer, this revi Read More
-
-
-
Cytotoxic Effects Of Lecaniodiscus Cupanioides (Planch.) Extract and Triterpenoids-derived Gold Nanoparticles On MCF-7 Breast Cancer Cell Lines
Available online: 27 January 2025More LessBackground The prevalent disease known as breast cancer has a significant impact on both men's and women's health and quality of life. Aim The aim of this study was to explore the potential roles of Lecaniodiscus cupanioides (planch.) extract and triterpenoid-derived gold nanoparticles (AuNPs) in cancer therapy, specifically targeting MCF-7 breast cancer cell lines. Methods Gold nanoparticles were synthesized utilizing tri Read More
-
-
-
Adenoviral Therapy for Cervical Cancer: From Targeted Modification to Immunotherapy
Authors: Yufeng Li, Haibin Zhang, Wenhu Xin and Tiansheng QinAvailable online: 27 January 2025More LessCervical cancer is a significant global health threat, ranking as the fourth most common malignancy among women and resulting in over 300,000 deaths annually. Although screening and vaccination initiatives have led to a decline in incidence rates, treatment options for advanced or recurrent cervical cancer remain inadequate, often proving ineffective and costly. In this context, adenoviral therapy has emerged as a promising Read More
-
-
-
Harnessing Therapeutic Potential of Allicin Against Cancer: An Exploratory Review
Authors: Anmol Saini, Vishakha Saini, Geeta Deswal, Bhawna Chopra, Ajmer Singh Grewal and Ashwani K. DhingraAvailable online: 23 January 2025More LessBackground The biological name of garlic is Allium sativum L., a familiar spice with various health benefits. These benefits are mainly attributable to the compound diversity of garlic, which includes saponins, polysaccharides, organic sulfides, and phenolic compounds. Allicin exhibits therapeutic activity such as antibacterial, anticancer, anti-inflammatory, immunomodulatory, anti-diabetic, and cardiovascular protection. This pres Read More
-
-
-
Potentials of N-Acyl hydrazones Against Colorectal Cancer: A Mini Review
Available online: 23 January 2025More LessColorectal cancer (CRC) is a malignant gastrointestinal tract disorder with high occurrence and mortality index and showing an upsurge. Standard therapies for treating CRC are surgery and chemotherapy. Despite great effort in developing effective treatments, the progress is limited due to its relapse and recurrence. Prognosis of metastatic CRC is always complicated. This condition can be evaded by a novel approach i.e., targ Read More
-
-
-
Quinacrine Inhibits Hepatocellular Carcinoma Growth and Enhances the Anti-HCC Effects of Lenvatinib
Authors: Binhe Xu, Minli Hu, Hui Yang and Weikang XuAvailable online: 22 January 2025More LessBackground Hepatocellular Carcinoma (HCC) is a highly prevalent cancer worldwide, necessitating effective treatment options. However, current treatments do not provide satisfactory results. Quinacrine, a synthetic drug belonging to the 9-aminoacridine family, has demonstrated promising antitumor effects. Objective The objective of the current study is to evaluate the anti-HCC effect of Quinacrine and explore whether quin Read More
-
-
-
Processed Products of Aconitum soongaricum Stapf. Inhibit the Growth of Ovarian Cancer Cells In vivo via Regulating the PI3K/AKT Signal Pathway
Authors: Xiaojuan Li, Xinle Tang, Liang Chen, Xingxing Cao, Reziya Ailimujiang, Qian Li and Feicui ZhaoAvailable online: 22 January 2025More LessIntroduction/Objective The alkaloids of songorine, aconitine, and benzoylaconitine, as the processed products of Aconitum soongaricum Stapf., can significantly inhibit the migration and invasion of ovarian cancer cells in vitro. Herein, we studied the in vivo role and mechanism of these natural products in processed A. soongaricum Stapf. Methods A xenograft tumor model was constructed. Tumor volumes and weights were calc Read More
-
-
-
Anticancer Properties of Phenylboronic Acid in Androgen-Dependent (LNCaP) and Androgen-Independent (PC3) Prostate Cancer Cells via MAP Kinases by 2D and 3D Culture Methods
Available online: 20 January 2025More LessObjective This study utilized three cell lines: normal prostate epithelial RWPE-1, androgen-dependent LNCaP, and androgen-independent PC3. We investigated the inhibitory effects of phenylboronic acid (PBA)’s inhibitory effect on cellular proliferation due to its ability to disrupt microtubule formation in prostate cancer cell lines. Additionally, this study aimed to assess the cytotoxic effects of PBA on prostate cancer cells using Read More
-
-
-
Safety and Efficacy of Anlotinib-based Regimen in Patients with Unresectable or Metastatic Bone and Soft-tissue Sarcomas: A Retrospective Institutional Study
Authors: Lina Pang, Shengli Zhang, Liye Wang, Shuai Gong and Wei HeAvailable online: 16 January 2025More LessBackground Anlotinib has demonstrated durable clinical benefits in patients with unresectable or metastatic bone and soft-tissue sarcomas. Methods 92 patients treated with chemotherapy combined with or without anlotinib were collected and analyzed. The objective response rate (ORR) and disease control rate (DCR) were analyzed. Long-term survival was assessed using the Kaplan-Meier method, including median Read More
-
-
-
Uses of Cyclohexan-1,3-diones to Synthesis Xanthenes Derivatives with Anti-proliferative Activity Against Cancer Cell Lines and their Inhibitions Toward Tyrosine Kinases
Authors: Rafat Milad Mohareb, Nadia Y. Megally Abdo and Marwa Shokry IbrahimAvailable online: 16 January 2025More LessBackground Xanthene derivatives are a notable class of heterocyclic compounds widely studied for their significant biological impact. These molecules, found in both natural and synthetic forms, have attracted substantial scientific interest due to their broad spectrum of biological activities. The xanthene nucleus, in particular, is associated with a range of potential pharmaceutical properties, including antibacterial, Read More
-
-
-
Irisquinone's Anti-cancer Potential: Targeting TrxR to Trigger ROS-mediated Apoptosis and Pyroptosis
Authors: Qifeng Zhang, Xinyan Wang, Gegen Tana, Guodong Liang, Yuheng Ma, Ren Bu and Lu GaAvailable online: 15 January 2025More LessBackground Irisquinone, an important compound extracted from Semen Irisis, has been used clinically as a radiotherapy sensitizer for lung, oesophageal, head and neck, breast and leukemia cancers. However, the mechanism by which it acts against cancer is still unclear. Objective The present study aims to investigate the anti-tumor activity and mechanism of Irisquinone. Methods The effect of Irisquinone on cell viabilit Read More
-
-
-
Investigation of the Anticarcinogenic Effects of Hypericum perforatum Extract on Human Thyroid Cancer
Authors: Çiğdem Gökçek-Saraç, Gizem Altunkaya and Serdar KarakurtAvailable online: 14 January 2025More LessIntroduction/Objective Plants and their bioactive compounds play a crucial role in the pharmaceutical industry for treating cancer. To date, the cytotoxic and antiproliferative effects of Hypericum perforatum methanol extract on human thyroid cancer cell lines have not been thoroughly explored. The present study aimed to assess the potential anti-cancer effects of HPME on human thyroid cancer and investigate its pote Read More
-
-
-
KW2478 and Cisplatin Synergistically Anti-colorectal Cancer by Targeting PI3K/AKT/mTOR Pathway
Authors: Jianping Wang, Jun An, Lixuan Tian, Yuzi Jin, Yalei Li, Peijian Ding, Wenjing Yun, Yunpeng Zhang and Shuang ZhaoAvailable online: 14 January 2025More LessObjective The objective of this study is to examine the impact of KW-2478 combined with DDP on colorectal cancer cells both in vitro and in vivo and to elucidate the molecular mechanism of KW-2478 in colorectal cancer. Methods qRT-PCR and Western blot were employed to assess HSP90 mRNA and protein expression in normal intestinal epithelial and colorectal cancer cells. DLD-1 and HCT116 were selected for the experi Read More
-
-
-
An Insight into Research Advances on Herbal and Phytochemical Approaches to the Management of Hepatocellular Carcinoma from January 2020 to July 2024
Authors: Zulfa Nooreen, Sunil Harer, Awani Kumar Rai, Ankita Wal, Deepak Nathiya and Parjinder KaurAvailable online: 13 January 2025More LessBackground Hepatocellular Carcinoma (HCC) is a primary hepatic tumor and is one of the world's third most frequent malignancies after lung and colorectal. After stomach, lung, and colorectal cancers, it is the most common cause of cancer-related mortality. Since the Palaeolithic era, herbs have been used as an essential source of alternative drugs. Modern cancer treatments that use chemotherapeutic medications are mad Read More
-
-
-
Schisanhenol Inhibits the Proliferation of Hepatocellular Carcinoma Cells by Targeting Programmed Cell Death-ligand 1 via the STAT3 Pathways
Authors: Zhihong Zhang, Yiwen Zhong, Xu Han, Xueyang Hu, Yuhan Wang, Lei Huang, Siying Li, Ziqing Li, Chunmei Wang, He Li, Jinghui Sun, Wenyue Zhuang, Mengyang Wang, Jianguang Chen, Wei Liu, Chang Liu, Xin Guo, Siyu Yuan and Jiping WuAvailable online: 10 January 2025More LessBackground Programmed cell death-ligand 1 (PD-L1) is overexpressed in tumor cells, which promotes tumor cell survival and cell proliferation and causes tumor cells to escape T-cell killing. Schisanhenol, a biphenyl cyclooctene lignin-like compound, was extracted and isolated from the plant named Schisandra rubriflora (Franch.). Purpose In this work, we studied the anticancer potential of schisanhenol and explored whether s Read More
-
-
-
Advances in VEGFR Inhibitors: A Comprehensive Review of Novel Anticancer Agents
Authors: Sumeet Jha, Sneha Gupta, Supriya Rani, Pinky Arora, Neeraj Choudhary and Shubham KumarAvailable online: 10 January 2025More LessCancer, characterized by aberrant cell growth, presents a formidable health challenge, impacting millions of individuals worldwide each year. Among the myriad mechanisms facilitating tumor progression, Vascular Endothelial Growth Factor receptors (VEGFR) play a pivotal role in driving angiogenesis the process by which tumors develop their own blood supply. This vascularization not only supports tumor nourishment an Read More
-
-
-
N-Degron PROTACs as a Potential Therapeutic Approach for Chronic Myeloid Leukemia
Authors: Grace Hohman and Mohamed A. EldeebAvailable online: 08 January 2025More LessMany oncoproteins are important therapeutic targets because of their critical role in inducing rapid cell proliferation, which represents one of the salient hallmarks of cancer. Chronic Myeloid Leukemia (CML) is a cancer of hematopoietic stem cells that is caused by the oncogene BCR-ABL1. BCR-ABL1 encodes a constitutively active tyrosine kinase protein that leads to the uncontrolled proliferation of myeloid cells, which is a h Read More
-
-
-
Design and Evaluation of 5-Oxo-1,2,4-triazole-3-carboxamide Compounds as Promising Anticancer Agents: Synthesis, Characterization, In vitro Cytotoxicity and Molecular Docking Studies
Authors: Rajitha Balavanthapu and Girija Sastry VedulaAvailable online: 06 January 2025More LessBackground Cancer presents a significant global health challenge, necessitating effective treatment strategies. While chemotherapy is widely employed, its non-specific nature can induce adverse effects on normal cells, prompting the exploration of targeted therapies. The 1,2,4-triazole scaffold has emerged as a promising element in anticancer drug development due to its structural diversity and potential to target canc Read More
-
-
-
Anti-metastasis Effects and Mechanism of Action of Curcumin Analog (2E,6E)-2,6-bis(2,3-dimethoxybenzylidene) Cyclohexanone (DMCH) on the SW620 Colorectal Cancer Cell Line
Available online: 06 January 2025More LessBackground Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths. Curcumin has been reported to have suppressive effects in CRC and to address the physiological limitations of curcumin, a chemically synthesized curcuminoid analog, known as (2E,6E)-2,6-Bis (2,3-Dimethoxy benzylidine) cyclohexanone (DMCH), was developed and the anti-metastatic and anti-angiogenic properties of DMCH in color Read More
-
-
-
Heavy Metals Alter the Anti-cancer Potency of Medicinal Plants
Authors: Amber Rizwan, Aatiquah Aqeel, Aisha Idris and Humaira FarooqiAvailable online: 06 January 2025More LessThis review investigates the outcome of heavy metal contamination on the anti-cancer properties of medicinal plants. Heavy metal pollution is a significant environmental concern globally, often found in soil and water due to industrial activities. Therapeutic plants are recognized because of their therapeutic attributes and their ability to absorbing these contaminants. This study examines how heavy metal exposure modifies t Read More
-
-
-
Antibody Drug Conjugates (ADCs): Shaping the Future of Precision Oncology
Available online: 06 January 2025More LessAntibody-drug conjugates (ADCs) are a groundbreaking advancement in targeted cancer therapy, combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. This review first outlines the components of ADCs and their mechanisms of action before providing a comprehensive overview of the current state of ADC technology. It covers both FDA-approved ADCs and those in various stages of clinic Read More
-
-
-
Selected Metal (Au, Ag, and Cu) Complexes of N-heterocyclic Ligands as Potential Anticancer Agents: A Review
Available online: 03 January 2025More LessNitrogen-based organic heterocyclic compounds are an important source of therapeutic agents. About 75% of drugs approved by the FDA and currently available in the market are N-heterocyclic organic compounds. The N-heterocyclic organic compounds like pyridine, indole, triazoles, triazine, imidazoles, benzimidazoles, quinazolines, pyrazoles, quinolines, pyrimidines, porphyrin, etc. have demonstrated significant biolo Read More
-
-
-
The Function of Poly (U) Binding Splicing Factor 60 (PUF60) in Disease Regulation
Authors: Huijuan Chen, Tian Guan, Jingfeng Song and Yihua ChenAvailable online: 03 January 2025More LessThe alternative splicing (AS) of pre-mRNA is an important process in controlling the expression of human genes, which can enrich the diversity of the proteome and regulate gene function. On the contrary, aberrant splicing contributes significantly to numerous human diseases progression, including tumors, neurological diseases, metabolic diseases, infections, and immune diseases. The PUF60, a protein related to RNA splici Read More
-
-
-
The Dual Role of ADAMTS9-AS1 in Various Human Cancers: Molecular Pathogenesis and Clinical Implications
Authors: Haodong He, Jingjie Yang, Yan Zhou, Xinyan Zheng, Lihan Chen, Zhujun Mao, Chuyuan Liao, Tongtong Li, Haoran Liu, Gang Zhou, Houdong Li and Chengfu YuanAvailable online: 03 January 2025More LessLong non-coding RNA (lncRNA) is a type of non-coding RNA distinguished by a length exceeding 200 nucleotides. Recent studies indicated that lncRNAs participate in various biological processes, such as chromatin remodeling, transcriptional and post-transcriptional regulation, and the modulation of cell proliferation, death, and differentiation, hence influencing gene expression and cellular function. ADAMTS9-AS1, an a Read More
-
-
-
Recent Prospectives of Cellular Signaling Role for Mammary Gland Carcinogenesis
Available online: 01 January 2025More LessIn women globally, breast cancer ranks as the second most frequent cause of cancer-related deaths, making up about 25% of female cancer cases, which is pretty standard in affluent countries. Breast cancer is divided into subtypes based on aggressive, genetic and stage. The precise cause of the problem is still unknown. However, the following significant risk factors have been found: sex, age, heredity, not having chil Read More
-
-
-
Discovery of a Novel Co-crystal of Chrysin and Oroxylin a with Anticancer Properties from Leaves of Oroxylum indicum
Available online: 13 December 2024More LessBackground As the number of new cancer cases increases every year, there is a necessity to develop new drugs for the treatment of different types of cancers. Plants' resources are considered to be huge reservoirs for therapeutic agents in nature. Among all the medicinal plants, Oroxylum indicum is one of the most widely used medicinal plants in India, China, and Southeast Asian countries. Combinatorial drug treatment, o Read More
-
-
-
Targeting Ferroptosis: Small-molecule Inducers as Novel Anticancer Agents
Authors: Shihao Jin, Huannan Wang, Zhen Zhang and Maocai YanAvailable online: 15 October 2024More LessFerroptosis, a distinct form of regulated cell death characterized by iron-dependent lipid peroxidation and reactive oxygen species (ROS) accumulation, is increasingly recognized for its role in cancer development and as a potential therapeutic target. This review consolidates insights into the molecular mechanisms underpinning ferroptosis and evaluates the therapeutic potential of small-molecule inducers, such as er Read More
-